Fiber Supplement Boosts Semaglutide Weight Loss in Overweight and Obese Adults
Background
Obesity and overweight are major global health challenges, often managed with medications like Semaglutide, a GLP-1 receptor agonist known for promoting significant weight loss. While effective, there's a continuous need for strategies to enhance its efficacy and improve patient outcomes. This study specifically investigated whether combining Semaglutide with a multi-component dietary fiber supplement (Soloways) could provide additional benefits for weight reduction and metabolic health in adults.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.